22nd Jan 2026 Pain control using liposomal bupivacaine after knee replacement surgical procedures: a plain language summary
22nd Sep 2025 A plain language summary of the LUMINA-1 study: bone imaging in patients with fibrodysplasia ossificans progressiva
25th Jun 2025 Plain language summary: emapalumab therapy for patients with rheumatologic conditions and hemophagocytic lymphohistiocytosis
25th Jun 2025 Plain language summary: how following multiple sclerosis medication prescriptions affects disease flare-ups, physical limitations, and medical expenses
23rd May 2025 Plain language summary: Real-world outcomes of SDZ ETN (etanercept biosimilar) treatment for rheumatic diseases in the COMPACT study
20th May 2025 Health outcomes and healthcare service use in older adults with and without multiple sclerosis: a plain language summary
22nd Apr 2025 Daily zilucoplan self-injections eased symptoms in people with generalized myasthenia gravis: Plain Language Summary of the RAISE Study
22nd Apr 2025 Plain language summary of the MycarinG study: Rozanolixizumab eased symptoms in people with generalized myasthenia gravis
19th Mar 2025 Plain language summary of key findings from the first Rare Bone Disease Summit: challenges and priority action
17th Mar 2025 A plain language summary of the combined safety findings of adalimumab-adbm from the VOLTAIRE clinical trials in individuals with rheumatoid arthritis, Crohn’s disease, and chronic plaque psoriasis
17th Jan 2025 Plain language summary of the pivotal study of calcium hydroxylapatite with lidocaine for improvement of jawline contour
26th Jun 2024 Anamorelin for the treatment of people with gastrointestinal cancer and cachexia: A plain language summary
26th Jun 2024 Anamorelin for the treatment of Japanese people with non-small cell lung cancer and cachexia: A plain language summary
23rd May 2023 Plain Language Summary: the MAIA study, daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
1st Mar 2023 The effects of palovarotene in patients with fibrodysplasia ossificans progressiva: a plain language summary
25th Nov 2022 The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey
20th Sep 2022 Plain language summary of the VOLTAIRE-RA study in patients with moderate-to-severe rheumatoid arthritis
20th Jun 2022 Prednisone and deflazacort in Duchenne muscular dystrophy: a patient perspective and plain language summary publication of the Cincinnati study
1st Dec 2021 Plain language summary of the long-term effect of ataluren in patients with Duchenne muscular dystrophy
